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Immunophenotyping using monoclonal antibodies (MAbs)
has become a widespread tool in the scientific, as well as
routine, pathological study of Non-Hodgkin's lymphoma
(NHL). Larger studies have suggested that not only different
histologically defined NHL subtypes, but also individual
cases of a single NHL subtype, may vary considerably in the
expression of leucocyte differentiation antigens (Schuurman
et al., 1987). The question, however, whether homo- or
heterogenous phenotypes correspond to genetically mono-
clonal or non-monoclonal lymphomas, respectively, has not
been investigated so far.
Richter's syndrome (RS), which is defined as the
emergence of a large cell lymphoma (LCL) in the course of a
chronic lymphocytic leukaemia (CLL) (Trump et al., 1980),
represents a unique condition for the study of this issue.
While a number of clearly biclonal RS have been described
(McDonnell et al., 1986; Ostrowski et al., 1989; Sklar et al.,
1984; Van Dongen et al., 1984), some cases seem to share a
common clonal origin despite the heterogenous morphology
of LCL and CLL tumors (Bertoli et al., 1987). These cases
thus offer an interesting opportunity to study the correlation
between monoclonality and differentiation antigen expres-
sion. For a detailed analysis of the immunophenotype, a
broad panel of MAbs can be used; these recognise lympho-
cyte surface antigens which have been extensively charac-
terised by the International Leucocyte Typing Workshops
(Knapp et al., 1989). In the case of B cell-derived tumours,
clonality can be assessed by probing for the variable parts of
the immunoglobulin antigen receptor on the protein and the
genomic level. Clonal rearrangements of the immunoglobulin
genes take place in normal as well as malignant B cells, thus
giving rise to unique restriction fragment length patterns and
immunoglobulin idiotype expression which both represent
exquisite markers for clonality (Arnold et al., 1983; Mayumi
et al., 1982).
We investigated the case of patient HK, a 47-year-old
male, who presented in 1980 with enlarged lymph nodes,
splenomegaly and a white blood cell count of 100,000 l-1.
Histological and immunohistochemical examination of three
lymph node biopsies from 1980 to 1982 confirmed the clinical
diagnosis of CLL with B cell phenotype. Having received
multiple courses of, initially mild and later aggressive,
chemotherapy regimens from 1981 to 1986, the patient
developed a rapidly progressive disease with fever, massive
lymph node enlargement, hepato- and splenomegaly, ascites
and cachexia in the beginning of 1987, leading to death
within four months. Clinical manifestation and progression
of the disease in patient HK appeared characteristic of RS,
as described in recent surveys (Trump et al., 1980).
At autopsy, a generalised lymphadenopathy, hepato- and
splenomegaly and diffuse blastomatous expansion of the
bone marrow was seen. In histological examination, the
enlarged lymph nodes and the bone marrow both showed
infiltration of small lymphocytes consistent with CLL. Fur-
thermore, large pleomorphic cells were found (Figure 1)
which had round to irregularly shaped nuclei with one or
multiple prominent nucleoli and moderately abundant,
strongly basophilic cytoplasm and a high mitotic rate consis-
tent with the histological diagnosis of a high grade malignant
lymphoma of the centroblastic, polymorphic subtype (CBp)
according to the Kiel classification (Lennert et al., 1978).
Diffuse infiltrations by CLL cells were detectable in the
splenic red and white pulp, the periportal tracts of the liver
and, to a lesser extent, in the lungs. In addition to a focal
intraparenchymatous liver infiltration, the CBp was found to
infiltrate the kidney interstitium and the peribronchiolar tis-
sue. The finding of typical admixed CLL and CBp infiltrates
confirmed the clinical diagnosis of RS in patient HK.
For immunohistochemical studies, cryostat sections of
snap frozen tissue specimens were stained by a modified
Figure 1 Lymph node with composite neoplastic involvement.
Strands of small lymphocytes are intermingled with large blastic
cells characterised by a small rim of cytoplasm, a round blastic
nucleus and small to medium sized nucleoli, thus resembling
centroblasts. Paraffin section from autopsy tissue, stained with
HE ( x 87.75). Scale bar= 50 1m.
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peroxidase method as described in detail elsewhere (Moller et
al., 1989). The results of three independent stainings per-
formed on bone marrow, lymph node and kidney tissue
samples, which are representative for all organs studied, are
listed in Table I. Both the CLL and CBp expressed high
amounts of HLA-A, B, C and HLA-DR antigens (Figure
2e). B cell origin of CLL and CBp could be demonstrated by
positive staining for 11 heavy and K light chain, for CD37
(Figure 2c), CD40 and gp8O. Interestingly, the B cell
differentiation antigens CD19, CD22 and CD24 (Figure 2a)
and CD5 and CD38 antigens were only expressed in CLL,
whereas the MHC class II sublocus product HLA-DQ
(Figure 2f) and the B cell related antigen CD23 (Figure 2b)
were detectable only in CBp. The non-neoplastic bone mar-
row cells were mainly composed of CD3 positive T cells,
most of them being of the cytotoxic/suppressor type.
To test whether the observed differences in the expression
of leucocyte differentiation antigens correlated with a bi-
clonal lymphoma in patient HK, two independent strategies
of probing for clonality were applied. Firstly, two mono-
clonal antibodies recognising idiotypic determinants on
purified HK tumour immunoglobulin were manufactured
using standard methods described previously in detail
(Moldenhauer et al., 1983). Specificity of MAbs AHK154
and AHK120 for HK tumour idiotype was demonstrated by
binding to HK tumour IgM, but not to four unrelated IgM
and two IgG (data not shown); and binding to cryopreserved
HK tumour cells, but not to a panel of unrelated lymphomas
and normal B cells in an ELISA on mildly fixed cells (data
not shown). When MAbs AHKI54 and AHKI20 were ap-
plied to immunohistochemical staining of HK tumour tissues,
CLL and CBp tumour cells in all organs analysed equally
stained for both idiotypic determinants (Figure 2d). In addi-
tion, when cryopreserved peripheral blood tumour cells from
1985 were analysed for cell surface expression of idiotypic
determinants by flow cytometry all tumour cells (amounting
to more than 98 per cent of peripheral blood lymphocytes)
again reacted with MAbs AHK154 and AHK120 (data not
shown). Thus the idiotypic determinants recognised by the
two MAbs had been present in all peripheral blood tumour
cells from two years before the clinical onset of RS, and were
equally displayed by CLL and CBp cells at autopsy.
To gain further evidence for the clonal origin of CLL and
CBp cells, we applied immunoglobulin gene probing to HK
tumour material. Genomic DNA from autopsy HK tumour
tissues and from HK PBL from 1985 was extracted with
standard procedures, digested with appropriate restriction
enzymes and blotted onto GeneScreen Plus membranes
(NEN, Boston, MA). For hybridisations, a 5.5 kb genomic
BamHI/HindIII fragment spanning the human immuno-
globulin heavy chain joining region (Arnold et al., 1983) was
labelled with a random oligo-primed DNA labelling kit
(Boehringer, Mannheim, FRG). An identical rearrangement
of both immunoglobulin heavy chain gene alleles was
detected in all samples analysed. Following digestion with
BamHI and HindIlI simultaneously, two rearranged bands of
2.8 and 1.6 kb with equal intensity showed up in addition to
a faint band of 4.6 kb which represented residual normal
lymphocytes or non-lymphoid tissues with a germline
immunoglobulin gene configuration (Figure 3). Equivalent
patterns with two rearranged alleles and a minor germline
band were produced by digestions with SstI, PstI and BglII
enzymes or combinations of these. This pattern indicates a
rearrangement of both immunoglobulin heavy chain genes in
a single B cell clone which is not an unusual finding in
lymphomas (Arnold et al., 1983). It cannot be explained by
the presence of two independent B cell clones with a single
rearrangement each. In this case the two unrearranged alleles
would result in a germline band with an approximately
twofold increase in intensity compared with the rearranged
bands. Thus a single B cell clone with a rearrangement of
both heavy chain alleles was detected in all tumour tissues
from 1985 and 1987.
In summary, CLL cells from more than one year before
the clinical onset of RS, and autopsy CLL and CBp tumour
Table I Immunophenotypic marker
samples
studies on HK tumour
Reactivity in
Antigen Clone CLL CBp
CD2 OKTll - -
CD3 Leu4 - -
CD4 OKT4 - -
CD5 OKT1 + -
CD8 OKT8 - -
CD38 OKTIO - +
CD1O J5
CD19 HD37a +
CD20 1F5 + +
CD21 B2 - -
CD22 HD39a +
CD23 HD50a - +
CD24 VIB-E3 + -
CD37 HD28a + +
CD40 G28-5 + +
CD53 HD77a + +
HLA-A,B,C W6/32 + +
HLA-DR ISCR3 + +
HLA-DP B7/21 + +
HLA-DQ Ti22 - +
Inv. Chain VIC-Y1 + +
CDI Ic LeuM5 - -
CD13 My7 - -
CD14 BEAR2 - -
CD15 LeuMl - -
CD30 Ki-I - -
FMC7 - -
Vimentin V9 + -
gp8O G28-8 + +
HK-Idiotype AHK154.3a + +
HK-Idiotype AHK120.8a + +
Lambda 1-155-2
kappa NHV361a + +
IgM NLH205a + +
IgG 8a4
aAntibodies produced in our laboratory. MAbs to differentiation
antigens are described in 'Leucocyte Typing IV' (Knapp et al., 1989).
tissues displayed an identical idiotype expression and
immunoglobulin gene rearrangement. Given the extremely
low probability for a common rearrangement with a shared
idiotype in two independent tumours, these results clearly
demonstrate a common clonal origin of both CLL and CBp
tumour cells in the case presented. This is in accordance with
three other published cases of clearly monoclonal RS (Bertoli
et al., 1987; Michiels et al., 1989; Siegelman et al., 1985).
Table II summarises the findings of other authors who
investigated cases of RS and other B cell lymphomas display-
ing multiple histological types. Only cases with definite
evidence concerning clonality are included. A number of
conclusions can be drawn from these findings and the pre-
sented case. First, both monoclonal and biclonal lymphomas
can present in the clinical form of a RS; among published
cases, biclonal cases are predominant. Second, expression of
a common immunoglobulin isotype in CLL and LCL cells is
not sufficient to conclude monoclonality in RS. Only four out
of 11 cases which could be shown to be biclonal by analysis
of gene rearrangement presented with different immuno-
globulin isotypes in CLL and LCL cells. Third, except for
one report of a loss of IgD expression in the LCL (Bertoli et
al., 1987), a de novo expression or loss of differentiation
antigens has not been described in monoclonal cases of RS.
The fact that only discrepancies concerning CD5 expression
(four cases) and CD21 expression (one case) were reported in
biclonal RS tumours is probably due to the quite limited
number of differentiation antigens studied in the published
cases.
Althouth CLL and CBp cells in patient HK both
originated from one B cell clone having undergone immuno-250 P.M. VAN ENDERT et al.
Figure 2 Immunostained serial sections of bone marrow removed at autopsy (x 90). a, CD24 (VIB-E3) selectivity reacts with
small lymphoid cells corresponding to the B-CLL subpopulation (scale bar = 50jsm); b, CD23 (HD50) selectively stains the
centroblastic subset of the neoplastic population; c, CD37 (HD28) is expressed on both subsets of tumour cells; d, likewise,
anti-idiotypic monoclonal antibody AHK154 reacts with both B-CLL and CBp cells; e, HLA-DR antigens are expressed on small
and large tumour cells as determined by MAb ISCR3; f, In contrast, HLA-DQ antigen expression is restricted to the centroblastic
subset, as shown by reactivity with MAb Ti22.
globulin gene heavy chain rearrangement, they displayed a
distinct pattern of differentiation antigen expression. The
phenotype of CLL cells with expression of pan-B markers
CD19 and CD20, B-restricted markers CD22 and CD24 and
expression of CD5 is in accordance with the data obtained in
larger studies (Schuurman et al., 1987). CBp cells displayed
an immunophenotype (vimentin-, CD21-, CD30-, CD38+)
which is highly suggestive of a follicular centre cell stage of
maturation. Thus, morphological as well as immuno-
phenotypic criteria indicate a transition from chronic lym-
phatic leukaemia to a polymorphic centroblastic lymphoma.
The transition from CLL to CBp may have been caused by
mutational events not involving the immunoglobulin heavy
chain variable region. Translocations juxtaposing the
immunoglobulin light chain or heavy chain genes to a
number of oncogenes are commonly found in certain types of
B cell lymphomas. Such mutations were shown to lead to a
deregulation of the oncogenes and may, in part, be detectable
as rearrangements of the translocated gene sequences. Trans-
locations joining the bcl-2 oncogene to immunoglobulin
genes are found in 85 per cent of lymphomas with follicular
centre cell type and, in very rare cases, in CLL (Adachi et al.,
1989) and are thought to give rise mainly to indolent, slowly
progressive lymphomas with nodular architecture (Yunis et
al., 1987). Translocations involving the c-myc oncogene
together with immunoglobulin genes are found in the highly
malignant Burkitt lymphomas and are associated with a high
rate of cell proliferation (Taub et al., 1982). In addition,MONOCLONAL RICHTER'S SYNDROME 251
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Figure 3 Ig heavy chain gene rearrangement in HK tumour
tissue. lO g DNA, digested with BamHI and HindIII, was hy-
bridised with a 5.5 kb genomic fragment from the human
immunoglobulin heavy chain joining region. Filled arrows
indicate rearranged bands, the open arrow marks the germline
band. DNA samples were prepared from A: HK spleen, B: HT 29
(human colon carcinoma line), C: HK lymph node 1, D: buffy
coat from a healthy volunteer, E: HK lymph node 2, F: HK-PBL
from 1985, G: Jurkat T lymphoma line, H: HK bone marrow.
follicular lymphomas with a bc1-2 translocation may convert
into highly malignant lymphomas upon further transloca-
tional events involving the c-myc gene (De Jong, 1988).
Therefore, we asked whether a translocation of c-myc into an
immunoglobulin gene locus might have caused transforma-
tion of CLL cells to a highly malignant lymphoma with a
high rate ofproliferation. Owing to the lack ofviable tumour
cells from the clinical stage of RS, a cytogenetic analysis
could not be done. Therefore, genomic DNA from CLL and
Table n Clonality in published cases of Richter's syndrome
Phenotypic
differences
Ig Isotype Ig gene (losses in
Authors Cases in CLL/LCL re-arrangement LCL)
Splinter 1 dA/WC N.T. N.T.
Delsol I fuc*/^ N.T. N.T.
Chan 4a I identical N.T. 3/4: CD5
3 divergent
Michiels I Auc/lAC monoclonal No
Bertoli I t/p.A monoclonal IgD
Ostrowski I PtA/- biclonal No
McDonnell I yKC/ltA biclonal CD21
Van Dongen I PA/gK biclonal CD5
Sklar 3a 2 identical 3 biclonal N.T.
I divergent
Siegelman 7a 6 identical 5 biclonal N.T.
I divergent 2 monoclonal
aIncluding B cell lymphomas with two histological types without
involvement of CLL.
CBp tumour cells was analysed for a possible rearrangement
of the c-myc gene which might indicate a translocation.
Using a 300 bp PstI-fragment from the second exon of the
c-myc gene, identical patterns ofrestriction enzyme fragments
were obtained when DNA from both histological subsets of
HK lymphoma and DNA from control normal lymphocytes
was digested with PstI, SstI, SmaI and XhoI enzymes (data
not shown). Thus no evidence for a translocation involving
c-myc or other genetic events resulting in a clonal evolution
towards high grade malignancy can be provided in the case
presented.
Support was provided by the Tumorzentum Heidelberg Mannheim.
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